(Q24306916)

GOA release 2020-03-11

1 reference

Sang Myun Park

1

0 references

Han Young Jung

2

0 references

Hyun Ok Kim

3

0 references

Hyangshuk Rhim

4

0 references

Seung R Paik

5

0 references

Kwang Chul Chung

6

0 references

Jeon Han Park

7

0 references

Jongsun Kim

Platelet mitochondrial respiratory chain function in Parkinson's disease.

8

0 references

language of work or name

English

0 references

publication date

1 October 2002

0 references

published in

Blood

0 references

volume

100

0 references

issue

7

0 references

page(s)

2506-14

0 references

cites work

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Aluminum-induced structural alterations of the precursor of the non-A beta component of Alzheimer's disease amyloid

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Tissue-dependent alternative splicing of mRNA for NACP, the precursor of non-A beta component of Alzheimer's disease amyloid

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

NACP, a synaptic protein involved in Alzheimer's disease, is differentially regulated during megakaryocyte differentiation

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Molecular Mechanisms of Platelet Exocytosis: Requirements for α-Granule Release

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Synoretin--A new protein belonging to the synuclein family

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Platelets as a model for neurones?

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Alpha-synuclein and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Identification of two distinct synucleins from human brain

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Platelet morphology in Parkinson's disease: an electron microscopic study

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

[3H] dopamine uptake by platelet storage granules in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Measurement of secretion of lysosomal acid glycosidases

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

alpha-synuclein promotes mitochondrial deficit and oxidative stress

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Plasma uptake of dopamine and 5-hydroxytryptamine and plasma-catecholamine levels in patients with Huntington's chorea

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Human platelet calcium mobilisation in response to beta-amyloid (25-35): buffer dependency and unchanged response in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Stress-induced aggregation profiles of GST-alpha-synuclein fusion proteins: role of the C-terminal acidic tail of alpha-synuclein in protein thermosolubility and stability

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Induction of neuronal death by α-synuclein

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Wild-type but not Parkinson's disease-related ala-53 --> Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

alpha-Synuclein membrane interactions and lipid specificity

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Induction of neuronal cell death by Rab5A-dependent endocytosis of alpha-synuclein

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

The cytoskeleton of the resting human blood platelet: structure of the membrane skeleton and its attachment to actin filaments

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Mechanisms of actin rearrangements mediating platelet activation

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

1 reference

7 January 2021

Structural changes in alpha-synuclein affect its chaperone-like activity in vitro

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Family study of platelet membrane fluidity in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Platelet monoamine oxidase B activity in parkinsonian patients

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Platelet aggregation in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Uptake and efflux of 14C-dopamine in platelets: Evidence for a generalized defect in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021

Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD.V100.7.2506

7 January 2021